- $2.20bn
- $2.51bn
- $786.50m
- 48
- 58
- 98
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 631 | 643 | 746 | 604 | 787 |
Cost of Revenue | |||||
Gross Profit | 459 | 495 | 580 | 412 | 596 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 642 | 596 | 461 | 620 | 725 |
Operating Profit | -11.3 | 47.8 | 285 | -15.7 | 61.8 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -73.9 | -75 | 160 | -65.4 | -59.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -73.5 | -79.3 | 141 | -66.8 | -64.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -73.5 | -79.3 | 141 | -66.8 | -64.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -73.5 | -79.3 | 141 | -66.8 | -64.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.114 | -0.095 | 0.018 | -0.094 | -0.094 |